RDC 📈 Redcare Pharmacy - Overview
Exchange: XETRA • Country: Netherlands • Currency: EUR • Type: Common Stock • ISIN: NL0012044747
RDC: Pharmaceuticals, Beauty Products, Personal Care, Food Supplements
Redcare Pharmacy NV operates in online pharmacy business in the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France. It provides prescription and non-prescription over-the-counter pharmaceuticals, beauty and personal care products, and food supplements. The company was formerly known as Shop Apotheke Europe N.V. and changed its name to Redcare Pharmacy NV in June 2023. Redcare Pharmacy NV was founded in 2001 and is headquartered in Sevenum, the Netherlands. Web URL: https://www.redcare-pharmacy.com
Additional Sources for RDC Stock
RDC Stock Overview
| Market Cap in USD | 3,514m |
| Sector | Healthcare |
| Industry | Pharmaceutical Retailers |
| GiC Sub-Industry | Drug Retail |
| IPO / Inception |
RDC Stock Ratings
| Growth 5y | 40.2% |
| Fundamental | -8.86% |
| Dividend | - |
| Rel. Strength Industry | -94.2 |
| Analysts | - |
| Fair Price Momentum | 124.28 EUR |
| Fair Price DCF | 30.02 EUR |
RDC Dividends
No Dividends PaidRDC Growth Ratios
| Growth Correlation 3m | 58.4% |
| Growth Correlation 12m | 26.5% |
| Growth Correlation 5y | 1.5% |
| CAGR 5y | 25.14% |
| CAGR/Mean DD 5y | 0.58 |
| Sharpe Ratio 12m | 0.22 |
| Alpha | -17.06 |
| Beta | 0.75 |
| Volatility | 56.13% |
| Current Volume | 47.9k |
| Average Volume 20d | 59.6k |
What is the price of RDC stocks?
As of December 22, 2024, the stock is trading at EUR 136.20 with a total of 47,883 shares traded.
Over the past week, the price has changed by -15.75%, over one month by -8.36%, over three months by +11.40% and over the past year by +0.79%.
As of December 22, 2024, the stock is trading at EUR 136.20 with a total of 47,883 shares traded.
Over the past week, the price has changed by -15.75%, over one month by -8.36%, over three months by +11.40% and over the past year by +0.79%.
Is Redcare Pharmacy a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Redcare Pharmacy is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -8.86 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of RDC as of December 2024 is 124.28. This means that RDC is currently overvalued and has a potential downside of -8.75%.
Neither. Based on ValueRay Fundamental Analyses, Redcare Pharmacy is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -8.86 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of RDC as of December 2024 is 124.28. This means that RDC is currently overvalued and has a potential downside of -8.75%.
Is RDC a buy, sell or hold?
Redcare Pharmacy has no consensus analysts rating.
Redcare Pharmacy has no consensus analysts rating.
What are the forecast for RDC stock price target?
According to ValueRays Forecast Model, RDC Redcare Pharmacy will be worth about 136.7 in December 2025. The stock is currently trading at 136.20. This means that the stock has a potential upside of +0.35%.
According to ValueRays Forecast Model, RDC Redcare Pharmacy will be worth about 136.7 in December 2025. The stock is currently trading at 136.20. This means that the stock has a potential upside of +0.35%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 157.6 | 15.7% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 136.7 | 0.3% |